Cargando…

Health state utilities for non small cell lung cancer

BACKGROUND: Existing reports of utility values for metastatic non-small cell lung cancer (NSCLC) vary quite widely and are not all suitable for use in submissions in the UK. The aim of this study was to elicit UK societal based utility values for different stages of NSCLC and different grade III-IV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nafees, Beenish, Stafford, Megan, Gavriel, Sonia, Bhalla, Shkun, Watkins, Jessamy
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579282/ https://www.ncbi.nlm.nih.gov/pubmed/18939982 http://dx.doi.org/10.1186/1477-7525-6-84

Ejemplares similares

Estimating health state utilities in hemophagocytic lymphohistiocytosis
por: Nafees, Beenish, et al.
Publicado: (2021)

Health state utilities for metastatic breast cancer
por: Lloyd, A, et al.
Publicado: (2006)

A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension
por: Nafees, Beenish, et al.
Publicado: (2023)

Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review
por: Jovanoski, Nick, et al.
Publicado: (2023)

A Patient-Centered Utility Index for Non–Small Cell Lung Cancer in the United States
por: Swan, J. Shannon, et al.
Publicado: (2018)

Clinical utility of ramucirumab in non-small-cell lung cancer
por: Uprety, Dipesh
Publicado: (2019)

Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
por: Paracha, Noman, et al.
Publicado: (2018)

The Evolution of Therapies in Non-Small Cell Lung Cancer
por: Boolell, Vishal, et al.
Publicado: (2015)

Clinical and comparative utility of afatinib in non-small cell lung cancer
por: D’Arcangelo, Manolo, et al.
Publicado: (2014)

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
por: Rice, Shawn J., et al.
Publicado: (2021)

A public health manifesto
por: Bagenal, Jessamy
Publicado: (2022)

‘Utilization of telemetry monitoring for non-cardiac conditions in non-critical patients: what are the trends and perceptions amongst medical residents?’
por: Fayyaz, Beenish, et al.
Publicado: (2020)

The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer
por: Edwards, Camille V., et al.
Publicado: (2022)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
por: Kang, Jin, et al.
Publicado: (2021)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
por: Turtle, Louise, et al.
Publicado: (2021)

Managing neurogenic bowel dysfunction: what do patients prefer? A discrete choice experiment of patient preferences for transanal irrigation and standard bowel management
por: Nafees, Beenish, et al.
Publicado: (2016)

The ostomy leak impact tool: development and validation of a new patient-reported tool to measure the burden of leakage in ostomy device users
por: Nafees, Beenish, et al.
Publicado: (2018)

Clinical Utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
por: Faugeroux, Vincent, et al.
Publicado: (2014)

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
por: Shen, Haifeng, et al.
Publicado: (2022)

Proton beam therapy in non-small cell lung cancer: state of the art
por: Harada, Hideyuki, et al.
Publicado: (2017)

Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
por: Yan, Jessie T., et al.
Publicado: (2023)

Utility of Kynurenic Acid for Non-Invasive Detection of Metastatic Spread to Lymph Nodes in Non-Small Cell Lung Cancer
por: Sagan, Dariusz, et al.
Publicado: (2015)

The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer
por: Tateishi, Akiko, et al.
Publicado: (2020)

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
por: Barnet, Megan B., et al.
Publicado: (2018)

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
por: Togashi, Yosuke, et al.
Publicado: (2014)

Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
por: Morgan, Katherine M., et al.
Publicado: (2017)

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status
por: Kano, Hirohisa, et al.
Publicado: (2020)

DRP1 promotes lactate utilization in KRAS‐mutant non‐small‐cell lung cancer cells
por: Hu, Mangze, et al.
Publicado: (2020)

The Utility of Next-Generation Sequencing in the Treatment Decision-Making for Metastatic Non-Small-Cell Lung Cancer
por: Orlov-Slavu, Maria Cristina, et al.
Publicado: (2021)

PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer
por: Chopra, P., et al.
Publicado: (2020)

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer
por: Schouten, Robert D., et al.
Publicado: (2021)

Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment
por: Sato, Yoshiharu
Publicado: (2022)

Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments
por: Winstone, Julie, et al.
Publicado: (2015)

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States
por: Thomas, Anish, et al.
Publicado: (2015)

Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment
por: Meirelles, Isandra, et al.
Publicado: (2021)

Estimation of health state utilities in breast cancer
por: Kim, Seon-Ha, et al.
Publicado: (2017)

Endoscopic Glucocorticoid Injection for the Treatment of a Refractory Benign Esophageal Stenosis in a Patient With Plummer-Vinson Syndrome
por: Jessamy, Kegan, et al.
Publicado: (2023)

Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea
por: Kim, Eun-Jung, et al.
Publicado: (2018)

Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers
por: Karve, Sudeep J, et al.
Publicado: (2014)

What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?
por: Lloyd, Andrew J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_29m2d7ej28i1avvmr4hmo53t5c